A Phase 2/3 interventional study of Medical ultrasound device (ShearWave system) in Thyroid Nodules, sponsored by AdministrateurCIC. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-01-25.
Sponsored by AdministrateurCIC · Phase 2/3, Interventional, and Diagnostic
Define an ultrasound/elastography benignity criteria in strategy management of a patient population carries one or more thyroid nodules.
Exclusion Criteria:
Device: Medical ultrasound device (ShearWave system)
Echography (all modes) and elastography "ShearWave" system
Defined echo/elastography benignity criteria
For ultrasound and elastography benignity criteria which will be retained, outcome focus on cytoponctions number for benin nodules can be avoided by taking into account this benign criteria
Time frame: two and half years
Evaluate the diagnostic performance of elastography ShearWave for characterization of thyroid nodules in a population of patients referred for needle biopsy or surgery nodule thyroid
ROC curves for performance of ultrasound, elastography and their coupling, compared to the reference cytology / histology.
Time frame: two and half years
Assessing the use of elastography in clinical practice
Time frame: two and half years
This study is completed, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
AdministrateurCIC